836th PORT ANNIVERSARY from 9 to 11 May to celebrate the heart of Hamburg
(Hamburg, Germany) With two new, spectacular evening shows on the floating stage on the river Elbe, breathtaking fireworks, magnificent parades featuring majestic windjammers, and many other new programme highlights, the people of Hamburg and their guests will celebrate the 836th HAMBURG PORT ANNIVERSARY.
Attention-grabbing highlights
On Thursday at 01:00 pm, the grand Arrival Parade will reach the port. Tall ships such as “Dar Młodzieży” and “Alexander von Humboldt II” along with numerous sailing ships large and small will enter the port to the delight of the admiring guests. This enthralling scenery will be enhanced by naval vessels, state-of-the-art specialised craft, tugboats, motor vessels, historic and museum ships, and countless sport boats.
On Saturday at 3:45 pm, the unique tugboat ballet will be performed against the backdrop of Hamburg Harbour. In a fascinating choreography, nimble tugs boasting up to 3000 hp will dance to music on the Elbe in an impressive symphony.
Elbe in Concert: Harbour at its best!
On Friday, beginning at 7:45 pm, guests can look forward to a spectacular evening show full of harbour atmosphere, presented on the floating stage on the river Elbe facing the landing stages. A programme featuring a harbour quiz, rousing live music, an XXL choir, and electrifying musical performances will celebrate Hamburg Harbour.
Elbe in Concert: Happy Birthday, Hamburg Harbour!
At 9:00 pm on Saturday, Guest will witness the enthralling live show on the spectacular Elbe stage facing the landing stages. Surprise star appearances will bring the mood at the port to the sizzling point. Guests will experience Hamburg characters chatting away and are sure get some real hoots too. The dazzling finale of the spectacular Happy Birthday show follows around 10:45 pm: When the music blends with the sparkling effects of the great fireworks, a breathtaking display of dancing colours and lights will light up the Elbe.
Contacts
Andrea HeydenHamburg Messe und Congress
andrea.heyden@hamburg-messe.deImages
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
INTERSPORT Austria acquires INTERSPORT Slovenia Group15.1.2026 15:16:10 CET | Press release
Strategic move strengthens market position in Central Europe, with over 500 locations in 12 countries and more than € 1 billion in sales
VORN Bioenergy announces appointments to leadership team15.1.2026 11:14:45 CET | Press release
Regensburg. VORN Bioenergy today announces the appointment of Jörg Lennertz as Chief Executive Officer and Manuel Fernández Durán as Chief Financial Officer. Jörg and Manuel together with Michael Wallis Olausson form the new management team.
Vyoma’s first Space Domain Awareness satellite has reached orbit13.1.2026 13:42:00 CET | Press release
Munich, 13. January 2026 - Vyoma, a Germany-based company providing Space Domain Awareness (SDA) capabilities, has launched its pioneering surveillance satellite, Flamingo-1, on Sunday, January 11th, 2026 from Vandenberg Space Force Base, California, USA. It was launched aboard the Twilight rideshare mission with SpaceX via Germany-based launch integrator Exolaunch. The satellite was deployed to its operational Sun-synchronous orbit of approximately 500-km in altitude. This marks a significant achievement for the company, which patented the operational concept of an optimized SDA mission. Flamingo-1, equipped with an optical sensor for space-based space surveillance, is a gamechanger for Europe, strengthening SDA efforts directly from orbit. The advanced optical instrument will detect, track and characterize space objects, such as debris and other satellites. Crucially, it will allow Vyoma and its customers to follow up on manoeuvring objects and derive insights into adversary actions
ORTEC expands German healthcare footprint with strategic acquisition of Klages & Partner13.1.2026 09:00:00 CET | Press release
Acquisition adds over 200 healthcare customers and sector-specific workforce management expertise to ORTEC’s portfolio
Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release
Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom